Outpost Medicine

Scroll
Investment area
Novo Ventures
Region
Eastern USA
Date of investment
February 2016
Website
http://www.outpostmedicine.com/

Outpost Medicine is developing novel therapeutics for the treatment of urologic and gynaecologic disorders. OP-233 is currently in phase 2 for the treatment of stress urinary incontinence.